Literature DB >> 19995558

LMO3 interacts with p53 and inhibits its transcriptional activity.

Steven Larsen1, Tomoki Yokochi, Eriko Isogai, Yohko Nakamura, Toshinori Ozaki, Akira Nakagawara.   

Abstract

High expression of LMO3 contributes to the development and aggressiveness of neuroblastoma. LMO3 belongs to the LIM-only protein family, in which de-regulation of its members is implicated in human carcinogenesis. However, the molecular mechanism of LMO3 activity in oncogenesis remained poorly characterized. We found that LMO3 is a direct interacting partner of p53 both in vitro and in vivo. The DNA-binding domain of p53 is required for this interaction. Furthermore, expression of LMO3 repressed p53-dependent mRNA expression of its target genes by suppressing promoter activation. Interestingly, chromatin immunoprecipitation assay showed that LMO3 facilitated p53 binding to its response elements. This suggests that LMO3 acts as a co-repressor of p53, suppressing p53-dependent transcriptional regulation without inhibition of its DNA-binding activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19995558     DOI: 10.1016/j.bbrc.2009.12.010

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  LIM-domain-only proteins: multifunctional nuclear transcription coregulators that interacts with diverse proteins.

Authors:  Meixiang Sang; Li Ma; Meijie Sang; Xinliang Zhou; Wei Gao; Cuizhi Geng
Journal:  Mol Biol Rep       Date:  2013-12-31       Impact factor: 2.316

2.  Cancer Progression Prediction Using Gene Interaction Regularized Elastic Net.

Authors: 
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2015-12-23       Impact factor: 3.710

3.  Lmo genes regulate behavioral responses to ethanol in Drosophila melanogaster and the mouse.

Authors:  Amy W Lasek; Francesco Giorgetti; Karen H Berger; Stacy Tayor; Ulrike Heberlein
Journal:  Alcohol Clin Exp Res       Date:  2011-05-20       Impact factor: 3.455

4.  miR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer.

Authors:  Ying-Fang Song; Jing-Fang Hong; De-Ling Liu; Qing-An Lin; Xiao-Peng Lan; Guo-Xiang Lai
Journal:  Am J Transl Res       Date:  2015-07-15       Impact factor: 4.060

5.  Increased behavioral responses to ethanol in Lmo3 knockout mice.

Authors:  A Savarese; M E Zou; V Kharazia; R Maiya; A W Lasek
Journal:  Genes Brain Behav       Date:  2014-09-24       Impact factor: 3.449

6.  Regulation of anxiety-like behavior and Crhr1 expression in the basolateral amygdala by LMO3.

Authors:  Antonia Savarese; Amy W Lasek
Journal:  Psychoneuroendocrinology       Date:  2018-03-27       Impact factor: 4.905

7.  Newly identified LMO3-BORCS5 fusion oncogene in Ewing sarcoma at relapse is a driver of tumor progression.

Authors:  Célia Dupain; Céline Gracia; Anne C Harttrampf; Julie Rivière; Birgit Geoerger; Liliane Massaad-Massade
Journal:  Oncogene       Date:  2019-09-05       Impact factor: 9.867

8.  A 6-gene signature identifies four molecular subgroups of neuroblastoma.

Authors:  Frida Abel; Daniel Dalevi; Maria Nethander; Rebecka Jörnsten; Katleen De Preter; Joëlle Vermeulen; Raymond Stallings; Per Kogner; John Maris; Staffan Nilsson
Journal:  Cancer Cell Int       Date:  2011-04-14       Impact factor: 5.722

9.  Gene expression profiles of metabolic aggressiveness and tumor recurrence in benign meningioma.

Authors:  Eva Serna; José Manuel Morales; Manuel Mata; José Gonzalez-Darder; Teresa San Miguel; Rosario Gil-Benso; Concha Lopez-Gines; Miguel Cerda-Nicolas; Daniel Monleon
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

10.  ICAD deficiency in human colon cancer and predisposition to colon tumorigenesis: linkage to apoptosis resistance and genomic instability.

Authors:  Youssef Errami; Hassan Brim; Karine Oumouna-Benachour; Mustapha Oumouna; Amarjit S Naura; Hogyoung Kim; Jihang Ju; Christian J Davis; Jong G Kim; Hassan Ashktorab; Kenneth Fallon; Ming Xu; Jianhua Zhang; Luis Del Valle; A Hamid Boulares
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.